{"id":20692,"date":"2023-11-29T09:00:00","date_gmt":"2023-11-29T08:00:00","guid":{"rendered":"https:\/\/www.a-stw.com\/?p=20692"},"modified":"2023-11-28T17:30:44","modified_gmt":"2023-11-28T16:30:44","slug":"medical-devices-drugs","status":"publish","type":"post","link":"https:\/\/www.a-stw.com\/en\/medical-devices-drugs\/","title":{"rendered":"The Intersection Between Medical Devices and Drugs: A Guide to Regulatory Compliance"},"content":{"rendered":"\n

The distinction between medical devices and drugs<\/strong> may seem clear, but there are areas of intersection where boundaries become blurred. Products such as drug delivery systems, which combine both aspects, require a deep understanding of the regulations for both categories. This short guide will explore these intersections and offer tips for ensuring compliance.<\/p>\n\n\n\n

1. Medical devices vs drugs: a fundamental distinction<\/h3>\n\n\n\n

Before diving into areas of overlap, it is vital to understand the main differences between medical devices and drugs in terms of definition, function, and regulation.<\/p>\n\n\n\n

2. When the device meets the drug<\/h3>\n\n\n\n

There are products, such as drug delivery systems or implantable drug-delivery devices, that combine the characteristics of both categories. As a result, their regulation becomes more complex.<\/p>\n\n\n\n

3. The combined regulatory framework<\/h3>\n\n\n\n

Italy, in line with the European Union<\/mark><\/a>, has specific guidelines for products combining medical devices and drugs. It is essential for companies to understand these regulations to ensure full compliance.<\/p>\n\n\n\n

4. Challenges in clinical trials<\/h3>\n\n\n\n

The testing of combination products poses unique challenges. They may require clinical studies that consider both the appearance of the device and the pharmacological aspect, complicating the approval process.<\/p>\n\n\n\n

5. Best practices for compliance<\/h3>\n\n\n\n

Companies should consider:<\/p>\n\n\n\n